Bloomage Biotech(SH:688363) 雪球·2025-07-27 05:49Core Viewpoint - The article discusses serious allegations against Huaxi Biological, a leading player in the medical aesthetics industry, regarding financial misconduct and governance issues, which have led to significant market concerns and a drastic decline in the company's stock price and market value [1][3][10]. Company Response - Huaxi Biological quickly responded to the allegations, stating that the claims are fabricated and maliciously distorted, and they have reported the matter to law enforcement [2][6][9]. Allegations and Background - The whistleblower, who claims to be a former key capital operator at Huaxi Biological, alleges financial fraud and governance failures, asserting possession of 450,000 words of insider material intended for regulatory submission [1][3][8]. - The whistleblower previously held a position as the marketing director at Huaxi and was involved in a case of embezzlement amounting to 9 million yuan, which led to a police report by the company [8]. Market Impact - Following the allegations, Huaxi Biological's stock price has seen a dramatic decline, from a peak of 314.99 yuan per share in July 2021 to approximately 53.83 yuan per share, representing a drop of over 80% and a market capitalization reduction from over 1,000 billion yuan to 259 billion yuan [11][13]. Financial Performance - The company's financial performance has deteriorated significantly, with a reported revenue of 5.371 billion yuan in 2024, down 11.61% year-on-year, and a net profit of 174 million yuan, down 70.59%, marking the largest annual decline since its listing [13][14]. - In comparison, competitors like Juzhi Biological and Jinbo Biological have shown strong growth, with Juzhi achieving a revenue increase of 57.07% and a net profit growth of 42.06% in 2024 [13][14]. Industry Context - The medical aesthetics industry is undergoing intense competition, with Huaxi Biological facing challenges from competitors like Juzhi Biological, which has seen its market value rise significantly [16][18]. - The article highlights a shift in consumer expectations towards product safety and efficacy, indicating that mere concept marketing is no longer sustainable, and companies must possess genuine technological advantages to succeed [21].